Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000884731-16-000040
Filing Date
2016-05-02
Accepted
2016-05-02 17:29:26
Documents
3
Period of Report
2016-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146222455271260.html 4  
1 FORM 4 wf-form4_146222455271260.xml 4 6804
2 COLE POA hughcole001.jpg GRAPHIC 206779
3 COLE POA hughcole.htm EX-24 584
  Complete submission text file 0000884731-16-000040.txt   293722
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Issuer) CIK: 0000884731 (see all company filings)

EIN.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARIAD PHARMACEUTICALS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cole Hugh M (Reporting) CIK: 0001604646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36172 | Film No.: 161612918